Keywords

• Moxifloxacin suppiler
• Moxifloxacin
• high quality Moxifloxacin

Quick Details

• ProName: Moxifloxacin manufacture
• CasNo: 151096-09-2
• Molecular Formula: C21H25ClFN3O4
• Appearance: Detailed see specifications
• Application: fine chemicals,intermeidates
• DeliveryTime: Depend on the quantity client want
• PackAge: According to client's requirements
• Port: SHANGHAI,CHINA
• ProductionCapacity: Gram/Month
• Purity: 98.0%
• Storage: keep sealed and keep from direct light
• Transportation: According to client's requirements
• LimitNum: 0 Metric Ton
• Moisture Content: send with COA
• Impurity: send with COA

Superiority

Hangzhou ZeErRui Chemical Co., Ltd. located in Lingang industrial areas, our plant covers an area of 6000 square meters.ZeErRui dedicated to the development, production and marketing of chemicals. We have earned ourselves a good reputation at home and abroad with advanced technology, standardized management and well established service systerm.
Our advantage:
1.Modest price
2.Good quality
3.Excellent pre-sales and after-sales service
4.Custom service
We now have 3 labs mainly used for technology development and custom synthesis, if you need customize service,pls feel free to contact us.

Details

Product name:Moxifloxacin

CAS  NO.151096-09-2

Alias:moxifloxacin;(1's,6's)-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;maxioffoxacin;(4αs-cis)-1-cydopropyl-6-fluoro-1, 4-dihydro-8-methoxy-7-(octahydro-6h-pyrrolo[3, 4-b]pyridin-6-y1)-4-oxo-3-quinolinecarboxylic acid;avdox;186826-86-8 (hydrochloride);192927-63-2 (hydrochloride hydrate);actira (*hydrochloride*)

Molecular formula:C21H24FN3O4 

Molecular weight:401.43

Quality standard:Assay 98%, 99%

Physical and chemical properties:Melting point: 203-208°C

Storage conditions:sealed tightly, kept in dark place

Packaging specifications:5g;25g ;50g; 1KG;5KG, or following your demands

Uses:Fluoroquinolones antibiotics. DNA topoisomerase inhibitors can be used to treat social acquired pneumonia caused by Staphylococcus aureus, influenza bacilli and pneumococci, acute attack of chronic bronchitis and acute sinusitis. It belongs to the fourth generation of quinolones. It is a new generation of broad-spectrum antibiotics. It has strong antibacterial activity against common respiratory tract bacteria, such as Streptococcus pneumoniae, Haemophilus influenzae, Morahan catarrhalis and some Staphylococcus aureus, especially Streptococcus pneumoniae, It can be used in the treatment of acute sinusitis, acute attack of chronic bronchitis) and community-acquired pneumonia, as well as skin and soft tissue infection without complications. The product is characterized by almost no photosensitive reaction, good tissue penetration and high concentration in lung tissue. It is a good drug for the treatment of respiratory tract infection